Get the Stockscreener App
1.715
3.11%
-0.055
Compugen Ltd stock is traded at $1.715, with a volume of 282.68K.
It is down -3.11% in the last 24 hours and up +5.21% over the past month.
Compugen Ltd is a clinical-stage therapeutic discovery and development company utilizing its broadly applicable predictive computational discovery capabilities to identify novel drug targets and new biological pathways to develop therapeutics in the field of cancer immunotherapy. Its immuno-oncology pipeline consists of four clinical-stage programs, targeting immune checkpoints the company discovered computationally, COM701, COM902 and bapotulimab. The company's therapeutic pipeline of early-stage immuno-oncology programs consists of programs aiming to address various mechanisms of immune resistance, including myeloid targets.
See More
Previous Close:
$1.77
Open:
$1.78
24h Volume:
282.68K
Relative Volume:
0.78
Market Cap:
$165.56M
Revenue:
-
Net Income/Loss:
$1.60M
P/E Ratio:
57.17
EPS:
0.03
Net Cash Flow:
$-62.91M
1W Performance:
+0.29%
1M Performance:
+5.21%
6M Performance:
+15.88%
1Y Performance:
+0.29%
1-Day Range:
$1.665
$1.7968
1-Week Range:
$1.61
$1.80
52-Week Range:
$1.13
$2.66
Compugen Ltd Stock (CGEN) Company Profile
Compare CGEN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CGEN
Compugen Ltd
|
1.715 | 165.56M | 0 | 1.60M | -62.91M | 0.03 |
|
VRTX
Vertex Pharmaceuticals Inc
|
425.08 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
641.99 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
432.26 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
822.85 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.78 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Compugen Ltd Stock (CGEN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-13-25 | Initiated | Oppenheimer | Outperform |
| Aug-05-22 | Downgrade | Jefferies | Buy → Hold |
| May-26-20 | Resumed | JMP Securities | Mkt Outperform |
| May-13-20 | Initiated | Stifel | Buy |
| May-07-20 | Initiated | SVB Leerink | Outperform |
| Apr-22-20 | Initiated | ROTH Capital | Buy |
| Mar-24-20 | Initiated | SunTrust | Buy |
| Jan-16-20 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-29-18 | Initiated | Oppenheimer | Outperform |
| Feb-01-16 | Resumed | Oppenheimer | Outperform |
| Oct-15-15 | Initiated | FBR Capital | Outperform |
| Apr-23-15 | Resumed | Jefferies | Buy |
| Apr-21-15 | Initiated | Oppenheimer | Outperform |
| Feb-07-14 | Initiated | MLV & Co | Buy |
| Dec-28-09 | Reiterated | Cantor Fitzgerald | Buy |
| Jul-29-09 | Initiated | Cantor Fitzgerald | Buy |
View All
Compugen Ltd Stock (CGEN) Latest News
Analyzing recovery setups for Compugen Ltd. investorsEarnings Beat & Accurate Entry and Exit Point Alerts - newser.com
Real time social sentiment graph for Compugen Ltd.Insider Buying & Reliable Momentum Entry Alerts - newser.com
How interest rate cuts could boost Compugen Ltd. stockJuly 2025 Catalysts & Scalable Portfolio Growth Ideas - newser.com
What high frequency data says about Compugen Ltd.Weekly Trade Recap & Consistent Income Trade Recommendations - newser.com
Long term hold vs stop loss in Compugen Ltd.2025 Market Sentiment & Smart Investment Allocation Tips - newser.com
Can Compugen Ltd. rally from current levels2025 Trading Recap & Fast Gaining Stock Strategy Reports - newser.com
What indicators show strength in Compugen Ltd.Weekly Profit Analysis & Reliable Entry Point Trade Alerts - newser.com
How to interpret RSI for Compugen Ltd. stock2025 Big Picture & Growth Oriented Trade Recommendations - newser.com
How sentiment analysis helps forecast Compugen Ltd.2025 Top Gainers & Risk Controlled Daily Trade Plans - newser.com
Reversal indicators forming on Compugen Ltd. stockBuy Signal & Safe Capital Preservation Plans - newser.com
Is Compugen Ltd. stock a top pick in earnings seasonJuly 2025 Trade Ideas & Real-Time Market Sentiment Alerts - newser.com
Does Compugen Ltd. qualify in momentum factor screening2025 Dividend Review & Entry Point Confirmation Signals - newser.com
Is now a turning point for Compugen Ltd.Earnings Miss & AI Driven Stock Price Forecasts - newser.com
What catalysts could drive Compugen Ltd. stock higherEarnings Miss & Fast Gain Stock Trading Tips - newser.com
Is Compugen Ltd. forming a bottoming baseTrade Entry Report & Low Drawdown Momentum Trade Ideas - newser.com
Is Compugen Ltd a good long term investmentIndustrial Stocks Review & Unlock Free Weekly Portfolio Checkups - earlytimes.in
What analysts say about Compugen Ltd stockHigh Yield Income Stocks & Free Discover Massive Upside Stocks - earlytimes.in
How Compugen Ltd. stock trades before earningsTrade Volume Summary & Low Drawdown Investment Strategies - fcp.pa.gov.br
Compugen Ltd Stock (CGEN) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.27%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):